Inactief instrument

Andere talen Cipher Pharmaceuticals Inc Nasdaq

Aandelen

CA17253X1050

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders	14/06
Cipher Pharmaceuticals : Financial Document	10/05
Cipher Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
Cipher Pharmaceuticals Reports First Quarter 2024 Results	09/05
Cipher Pharmaceuticals Schedules Q1 2024 Earnings Release and Conference Call	06/05
Cipher Pharmaceuticals Schedules Q1 2024 Earnings Release and Conference Call	03/05
Cipher Pharmaceuticals Announces Participation in the 2024 Bloom Burton & Co. Healthcare Investor Conference	03/04
Tranche Update on Cipher Pharmaceuticals Inc.'s Equity Buyback Plan announced on November 15, 2023.	14/03
Cipher Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	14/03
Cipher Pharmaceuticals Q4 Profit Falls 61% on Charges	14/03
Cipher Pharmaceuticals Brief: Q4 Net income and earnings per common share were US$7.7 million and $0.32, respectively	14/03
Cipher Pharmaceuticals Brief: Q4 Total revenue was US$4.9 million, consistent with Q4 2022	14/03
Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results	14/03
Cipher Pharmaceuticals Schedules Q4 2023 Earnings Release and Conference Call	08/03
Cipher Pharmaceuticals Brief: Announcing that its common shares are now trading on the OTCQX Best Market	29/01
Cipher Pharmaceuticals Announces the Commencement of OTCQX Trading	29/01
Cipher Pharmaceuticals Announces Change of Auditor	27/11
Cipher Pharmaceuticals Announces Change of Auditor	24/11
Cipher Pharmaceuticals Announced Normal Course Issuer Bid	15/11
Cipher Pharmaceuticals Announces Normal Course Issuer Bid	15/11

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Cipher Pharmaceuticals Inc Nasdaq

Aandelen

CA17253X1050

Andere talen

Filters